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ABSTRACT
The effect was investigated of chloramphenicol on the activities of hepatic biotransformation enzymes: 
aniline hydroxylase (Ah) and ethylmorphine N-demethylase (EtND), as well as on the levels of serum alanine 
aminotransferase (ALT) and glutamate dehydrogenase (GLDH) in guinea pigs (Cavia porcellus). Moreover, 
the infl uence was established of  the pre-medication with chloramphenicol on the duration of anesthesia using 
pentobarbital and ketamine/xylazine guinea pigs. Male guinea pigs, weighing 269-353 g, were subcutaneously 
(s.c.) treated with 60- and 100 mg chloramphenicol sodium succinate/kg body mass once a day for three days. 
Thereafter the anesthetics were injected: 30 mg pentobarbital/kg b.m., i.p. in one group and 60 mg ketamine/kg 
b.m., s.c. + 4 mg xylazine/kg b.m., s.c. in the other group. Treatment with chloramphenicol did not signifi cantly 
affect the concentration of serum ALT or GLDH. As expected, 100 mg chloramphenicol/kg b.m. signifi cantly 
decreased the activity of Ah and EtND for -36.1% and -38.6%, respectively. On the other hand, the duration of 
pentobarbital anaesthesia and ketamine/xylazine-induced anaesthesia in chloramphenicol pre-treated animals 
was not signifi cantly prolonged. Our results also indicate that decreased enzyme activity in the presence of 
chloramphenicol did not infl uence the hepatic metabolism of two tested anaesthetics in guinea pigs, and in 
contrast to dogs, cats, rats and mice, did not prolong the duration of anaesthesia.
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Introduction
Many chemicals and environmental agents can alter the activity of drug metabolizing 
enzymes by induction and inhibition. Chloramphenicol has been shown to alter the 
pharmacokinetics of other drugs by inhibition of hepatic drug metabolizing enzymes 
(CHRISTENSEN and SKOVSTED, 1969; SMITH and WEBER, 1983). Chloramphenicol, the 
typical wide-spectrum antibiotic, is prohibited in Croatia in food producing animals. On 
the other hand, it is one of a few antibiotics available for oral and parenteral application 
to guinea pigs. The recommended therapeutic doses for guinea pigs are 50 mg/kg p.o. 
three times daily and 20 mg/kg i.m. twice daily. The inhibition of hepatic cytochrome 
P450-dependent monooxygenases by choramphenicol is well documented in a number of 
species, accompanied by altered biotransformation processes of concurrently used drugs 
(DIXON and FOUTS, 1962; ADAMS and DIXIT, 1970; TESKE and CARTER, 1971; ADAMS 
et al., 1977; KRANER et al., 1994; FAROMBI et al., 2002; PARK et al., 2003). Modulated 
levels of aniline hydroxylase (Ah) and ethylmorphine N-demethylase (EtNd) are relevant 
indicators of changes in hepatic biotransformation capacity. 
Xylazine, α2-adrenergic agonist with sedative, analgesic and muscle relaxant 
properties, is commonly used for anaesthesia in veterinary medicine. The combination 
of xylazine and ketamine produces suffi cient anaesthesia for most surgical procedures 
(GREENE and THURMON, 1988). Ketamine is a rapid-acting dissociative anaesthetic, 
and its pharmacological action is characterized by a good analgesia, normal pharyngeal-
laryngeal refl exes, respiratory depression and cardiac stimulation (WRIGHT, 1982).
Pentobarbital sodium, a short-acting barbiturate, was commonly used for anaesthesia 
in veterinary surgery before introduction of safe inhalation anaesthetics: halothane and 
methoxyfl urane, as well as an injectable anaesthetic ketamine. Though the intraperitoneal 
application of pentobarbital sodium to guinea pigs may be more appropriate than use of 
inhalation anaesthetics, the animals in pentobarbital-induced anaesthesia must be under 
constant supervision because of its possible side effects and relatively narrow therapeutic 
index of this barbiturate.
Pre-treatment of animals with P-450 inhibitors has been shown to prolong the duration 
of xylazine-ketamine anaesthesia in rats and chickens, or could have deleterious effects, 
such as death due to pulmonary oedema (AMOUZADEH et al., 1989; AMOUZADEH et al., 
1991). Duration of pentobarbital-induced anaesthesia in dogs, cats and several laboratory 
animal species may be prolonged by the concurrent administration of chloramphenicol 
(ADAMS, 1970; ADAMS and DIXIT, 1970, TESKE and CARTER, 1971; FREIRE et al., 1974). 
The guinea pig (Cavia porcellus) has been used extensively as a research model 
in many disciplines, although guinea pigs are not a genetically homogenous species as 
laboratory animal breeds, such as Sprague Dawley rats or B6C3F1 mice.
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The aims of this study were: 1. to investigate the effect of chloramphenicol on the 
duration of clinical anaesthesia in guinea pigs induced by either xylazine-ketamine 
combination or by pentobarbital, and 2. to test the effect of chloramphenicol on hepatic 
cytochrome P450-dependent monooxygenase activity of aniline hydroxylase (Ah) and 
ethylmorphine N-demethylase (EtND), as well as on serum alanine aminotransferase 
(ALT) and glutamat dehydrogenase (GLDH) activities in guinea pigs. 
Materials and methods
Experimental design. The experiment was carried out in two parts.
I. Part. Male guinea pigs, of roughly equal body mass (269-353 g), were divided 
into control C1 (n=6), and two experimental groups: K60 (n=6) and K100 (n=8). The 
animals were housed individually in wire-bottomed cages in a controlled environment 
(temperature, relative humidity and air fl ow velocity). A commercial diet for guinea pigs 
(Animal feed factory, Hrvatski Leskovac, Croatia) and water was supplied ad libitum 
throughout the study. 
One experimental group (K60) was treated with 60 mg chloramphenicol/kg b.m., 
whereas the second experimental group (K100) was treated with 100 mg chloramphenicol/
kg b.m., once a day for three consecutive days. The doses were chosen with a view to 
testing the effect of the drug on the biotransformation enzyme activity, but not to test 
its therapeutic effects. Chloramphenicol sodium succinate (Kloramfenikol, Pliva Ltd.) 
was administered subcutaneously (s.c.) as a fresh 5% water solution, as described before 
(SCHUCHMAN, 1989).
Animals were treated humanely, without causing unnecessary pain. They were 
sacrifi ced in the most rapid and least painful way, by cervical dislocation.
Activities of Ah and EtND were determined in the livers of all animal groups. The 
livers were promptly removed, weighed and placed immediately into ice-cold 1.15% KCl 
solution, thereupon pooled and homogenized with 3 volumes of ice-cold 0.25 M sucrose 
solution using a Potter Elvehjem-type tissue homogenizer. Homogenates were centrifuged 
at 4o C at 600×g for 5 min to remove cell debris. The supernatant was centrifuged at 
9000×g in a refrigerated WKF P-18 centrifuge and the resulting post-mitochondrial 
supernatant (S9 fraction) was used to measure the rate of hydroxylation of aniline and 
N-demethylation of ethylmorphine. Ah assay was performed following the procedure 
described by IMAI et al. (1969). The amount of p-aminophenol formed from aniline was 
determined colorimetrically. The ethylmorphine N-demethylation rate was assayed by 
measuring the formaldehyde formed from ethylmorphine chloride as described by NASH 
(1953) and COCHIN and AXELROD (1959). 
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Blood samples were collected by heart punction post mortem, and serum ALT and 
GLDH levels were measured within 24 hours using commercial Boehringer diagnostic 
kits.
The results of enzyme activities and protein concentration are presented as mean ± 
SEM. Data were analyzed using Student's t-test. The signifi cance of mean differences 
between controls and two experimental groups was based on a P value of <0.01. 
II. Part. Male guinea pigs of roughly equal body mass were divided into two 
control groups: Group 1) control C2 (n=8) and Group 2) control C3 (n=6), plus four 
experimental groups: Group 3) chloramphenicol 60 mg/kg b.m. + pentobarbital (K60p; 
n=7); Group 4) chloramphenicol 60 mg/kg b.m. + ketamine/xylazine (K60k/x; n= 6); 
Group 5) chloramphenicol 100 mg/kg b.m. + pentobarbital K100p (n= 7) and Group 
6) chloramphenicol 100 mg/kg b.m. + ketamine/xylazine (K100k/x; n=7). The animals 
were housed in wire-bottomed cages in a controlled environment. A commercial diet for 
guinea pigs (Animal feed factory, Hrvatski Leskovac, Croatia) and water was supplied 
ad libitum. 
Table 1. Treatment design for II part
Treatment group No of animals
Chloramphenicol 
dose (mg/kg b.m.)
Anesthetic used/ Dose 
administered (mg/kg b.m.)
1 C2 control 8 - Pentobarbital 30 mg
2 C3 control 6 - Ketamine 60/Xylazine 4
3 K60p 7 60 Pentobarbital 30 mg
4 K60k/x 6 60 Ketamine 60/Xylazine 4
5 K100p 7 100 Pentobarbital 30 mg
6 K100k/x 7 100 Ketamine 60/Xylazine 4
Animals from the two experimental groups (Groups 3 and 4) were pre-treated for 
3 days with 60 mg chloramphenicol/kg b.m., whereas the guinea pigs from other two 
experimental groups (Groups 5 and 6) were treated with 100 mg chloramphenicol/kg 
b.m. In both groups the animals were administered chloramphenicol for three days, once 
a day. Chloramphenicol sodium succinate was s.c. applied as fresh 5% water solution. 
After a three-day chloramphenicol treatment, the guinea pigs from one control and two 
experimental groups (C2, K60p and K100p) were weighed and anesthetized with 30 mg 
pentobarbital sodium/kg b.m., i.p. (Vetanarcol, Werfft Chemie, Wels, Austria), according 
to literature data (RAUB and GILLESPIE, 1976).
Simultaneously, the guinea pigs from the other control (C3) and other two experimental 
groups (K60k/x and K100k/x) were weighed and anesthetized with 60 mg ketamine/
kg b.m. (Ketonest 50, Parke-Davis Godecke) and 4 mg xylazine/kg b.m. (Rompun 2% 
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solution, Bayer plc.). Anaesthetics were applied s.c. in separate syringes. The doses were 
in accordance with literature data (SCHUCHMAN, 1989; FLECKNELL, 2005).
Duration of anaesthesia was measured in anesthetized animals as the time interval 
in minutes between the moment when the guinea pigs were laid down and the moment 
they stood up (immobilization time), and also as the time interval between the loss and 
recovery of the pedal refl ex.
The signifi cance of the difference in mean time of anaesthesia between control and 
test groups of guinea pigs was calculated by the Student’s t test. 
Results
The results of investigation are presented in 4 tables. The results are expressed as 
mean ± SEM and min-max values in brackets.
Biotransformation enzymes activity. Treatment with 100 mg chloramphenicol/kg 
b.m. signifi cantly suppressed the activity of both tested biotransformation enzymes.
Table 2. Effect of in vivo treatment with chloramphenicol on activities of ethylmorphine N-
demethylase (EtND) and aniline hydroxylase (AnH) in liver of guinea pigs
EtND (1)
x ± SE (min-max)
AnH (2) 
x ± SE (min-max)
 C1  n = 6 1536 ± 87 (1196-1800) 264 ± 24 (193-368)
 K60  n = 6 1633 ± 172 n.s. (1130-2201) 311 ± 27 n.s. (215-403)
 K100  n = 6 981 ± 121 ** (599-1317) 162 ± 34 * (85-315)
(1) nmol HCOH/g liver/30 min.; (2) nmol p-OH aniline/g liver/30 min.; C1-control; K60-chloramphenicol 60 mg/
kg b.m. s/c during 3 days; K100 - chloramphenicol 100 mg/kg b.m. s/c during 3 days; n = number of animals in 
a group; n.s. - not signifi cant ; * P<0.05; ** P<0.01. 
Duration of pentobarbital-induced anaesthesia. The results indicate that the 3-day-
pre-treatment with chloramphenicol did not signifi cantly prolong duration of pentobarbital-
induced anaesthesia although there was a numeric prolongation in both treatment groups. 
However, the absence of pedal refl ex was signifi cantly shorter in the K60p and K100p 
experimental groups of guinea pigs when compared to the control group.  
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Table 3. Effect of chloramphenicol on duration of pentobarbital-induced anesthesia (30 mg/kg 
i.p.) in guinea pigs
 Group
Duration of pentobarbital-induced anesthesia (1)
Immobilization time
 x ± SE (min-max)
Absence of pedal refl ex
x ± SE (min-max) 
 C2  n = 8 208 ± 12 (165-265) 129 ± 6 (111-141)
 K60p  n = 7 235 ± 15 n.s. (186-296) 81 ± 10 ** (47-122)
 K100p  n = 7 220 ± 19 n.s. (129-302) 86 ± 8 ** (59-107) 
(1) minutes; C2-control; K60p-chloramphenicol 60 mg/kg b.m. s/c during 3 days + 30 mg pentobarbital/kg b.m., 
i.p; K100p - chloramphenicol 100 mg/kg b.m. s/c during 3 days + 30 mg pentobarbital/kg b.m., i.p.; n = number 
of animals in a group; n.s. = not signifi cant; ** P <0.01.
Duration of ketamine/xylazine induced anesthesia. Similarly to previous results, the 
3-day-treatment with chloramphenicol did not signifi cantly prolong the immobilization 
time of ketamine/xylazine-induced anaesthesia, and the absence of pedal refl ex was 
signifi cantly shorter in the K60k/x experimental group of guinea pigs than in the control 
group. 
Table 4. Effect of chloramphenicol on duration of ketamine/xylazine-induced anesthesia (60 
mg/kg + 4 mg/kg b. w., s.c.) in guinea pigs
  Group
Duration of ketamine/xylazine-induced anesthesia (1)
Immobilization time
 x ± SE (min-max)
Absence of pedal refl ex
x ± SE (min-max) 
 C3  n = 6 138 ± 3 (128-147) 129 ± 5 (116-144)
 K60k/x  n = 6 152 ± 15 n.s. (122-222) 110 ± 2 ** (104-116)
 K100k/x  n = 7 132 ± 6 n.s. (115-164) 121 ± 2 n.s. (115-130) 
(1) minutes; C2-control; K60k/x-chloramphenicol 60 mg/kg b.m. s/c during 3 days + 60 mg ketamine/kg and 4 
mg xylazine/kg b.m., s.c; K100k/x - chloramphenicol 100 mg/kg b.m. s/c during 3 days + 40 mg ketamine/kg 
and 4 mg xylazine/kg b.m., s.c.; n = number of animals in a group; n.s. = not signifi cant; ** P<0.01.
ALT and GLDH activity. The serum values of ALT and GLDH activities in plasma of 
control and guinea pigs treated with 60- or 100 mg chloramphenicol/kg b.m. over 3 days 
were not signifi cantly different.
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Table 5. Effect of chloramphenicol on activity of alanine aminotransferase (ALT) and glutamate 
dehydrogenase (GLDH) in plasma of guinea pigs
 group ALT U/L GLDH U/L
 C1 n = 6 25.7 ± 2.6 (20.3-33.0) 6.6 ± 1.5 (1.9-11.9)
 K60 n = 6 21.8 ± 2.2 n.s. (16.7-30.0) 4.5 ± 1.3 n.s. (1.5-9.3)
 K100 n = 8 23.0 ± 0.9 n.s. (18.2-26.3) 11.5 ± 1.9 n.s. (5.9-18.2)
C1-control; K60-chloramphenicol 60 mg/kg b.m. s/c during 3 days; K100 - chloramphenicol 100 
mg/kg b.m. s/c during 3 days; n = number of animals in a group; n.s.-not signifi cant.
Discussion
Biotransformation enzymes activity. There are relatively quite a large number of papers 
describing hepatic biotransformation enzyme activity in guinea pigs, with investigations 
of the main hepatic cytochrome P450 enzymes activity being conducted with different 
aspects. In most cases they encompassed the response of these enzymes to different metals 
or other chemicals were tested (KITADA et al., 1977; ISCAN et al., 1993; LEE et al., 2002; 
KOGA et al., 2007). Also, purifi cation, characterization and molecular cloning of the guinea 
pig cytochrome P450-dependent enzymes (SHIMADA et al., 1997; SUZUKI-KURASAKI 
et al., 1997; MORI et al., 1998; YAMAMOTO et al., 2004). However, there are no reports 
of the infl uence of chloramphenicol on the hepatic biotransformation system in guinea 
pigs; the inhibitory effect of chloramphenicol on hepatic cytochrome P450-dependent 
monooxygenases, which is well documented in a number of species (DIXON and FOUTS, 
1962; ADAMS and DIXIT, 1970; TESKE and CARTER, 1971; ADAMS et al., 1977; HALPERT et 
al., 1988), was confi rmed in our study too, after application of 100 mg chloramphenicol/kg 
b.m. to guinea pigs. The decreased activity of aniline hydroxylase and ethylmorphine N-
demethylase appreciably alters the biotransformation processes of drugs which are used 
simultaneously. Administration of 60 mg chloramphenicol/kg b.m. did not inhibit the 
activity of the tested enzymes; indeed there was slight induction, but the dose of 100 mg 
chloramphenicol/kg b.w inhibited these enzymes, suggesting that the inhibition/induction 
of cytochrome P-450 by chloramphencol is dose-dependent in guinea pigs. 
ALT and GLDH activity. GLDH is primarily located in the hepatic mitochondria, and 
its activity is increased in the presence of a hepatic injury (KELLER, 1979). Our study 
demonstrates non-signifi cant changes of GLDH activity, due to wide-range variability 
in the serum GLDH levels. Moreover, the enhanced GLDH activity mean value in the 
livers of guinea pigs treated with 100 mg chloramphenicol/kg b.m. may be an indicator of 
hepatic injury. On the other hand, the wide-range GLDH activity values observed in the 
serum of the guinea pigs may be the consequence of population heterogeneity.
Chloramphenicol did not signifi cantly alter serum ALT activity. Induction of ALT 
activity in guinea pigs, as well as in other animal species is an indicator of a hepatic 
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and heart injury. This fi nding is in accordance with the investigation by HAPKE et al. 
(1977) who reported unchanged ALT activity in rats after i.p. application of 100 mg 
chloramphenicol/ kg b.m.
Effect of chloramphenicol on duration of anaesthesia. The chloramphenicol dose 
which results in a signifi cant prolongation of pentobarbital anesthesia ranges from 1-300 
mg/kg in dogs, cats, monkeys, rats, and mice (ADAMS, 1970; ADAMS and DIXIT, 1970; 
TESKE and CARTER, 1971; ADAMS et al., 1977; HALPERT et al., 1985b). A dose-independent 
prolongation of pentobarbital anaesthesia was noted in mice and dogs, respectively 
(ADAMS, 1970; TESKE and CARTER, 1971). In dogs there is a dose-dependent trend in 
prolongation of duration of anaesthesia and inhibition of cytochrome P-450 (NOSSAMAN 
et al., 1990). The dosage of 30 mg pentobarbital/kg b.m. administered to guinea pigs was 
within the therapeutic (anaesthetic) range normally used for anaesthesia in this species. 
In contrast to results gained by others in numerous other species, our results have shown 
that chloramphenicol pre-treatment did not prolong the duration of pentobarbital-induced 
anaesthesia in guinea pigs. The possible reasons could be the dose of chloramphenicol, as 
well as the duration of its application.
Likewise, the pre-treatment of guinea pigs with chloramphenicol did not signifi cantly 
prolong the duration of ketamine/xylazine-induced anaesthesia in our study, which is in 
accordance with the results of NOSSAMAN et al. (1990). Moreover, the i.v. application of 
a therapeutic dose of chloramphenicol did not alter the duration of ketamine/xylazine 
anaesthesia in dogs and mice (RODER et al., 1993). This is in contrast with the previous 
report showing that chloramphenicol might prolong the duration of xylazine/ketamine 
anaesthesia in rats (AMOUZADEH et al., 1989) and in broiler chickens (RODER et al., 1993). 
GARCIA-VILLER et al. (1981) suggest that xylazine is metabolized by hepatic cytochrome 
P450 drug metabolizing enzymes similar to ketamine. The mayor metabolic pathway 
of ketamine is N-demethylation by cytochrome P-450 enzymes (KAKA and HAYTON, 
1980). The signifi cantly shorter absence of pedal refl ex in the K60p, K100p and in the 
K60k/x experimental groups of guinea pigs than in the controls was unexpected. The 
reason for this is unknown yet. The failure of chloramphenicol to prolong pentobarbital 
and xylazine/ketamine anaesthesia in guinea pigs could be due to various factors. The 
hepatic cytochrome P450 enzymes are composed of specifi c isozymes. Chloramphenicol 
has been shown to inhibit only a few but not all of the isozymes of the P-450 complex 
(HALPERT et al., 1985a; HALPERT et al., 1985b). Since only specifi c cytochrome P-450 
enzymes are shown to be inhibited by chloramphenicol, it is also possible that isozymes 
involved in both pentobarbital and xylazine/ketamine metabolism in guinea pigs might 
not be affected by chloramphenicol. 
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SAŽETAK
U radu je istražen učinak kloramfenikola na aktivnost jetrenih biotransformacijskih enzima anilin 
hidroksilazu (Ah) i etilmorfi n N-demetilazu (EtND) te na razinu serumskih enzima alanin aminotransferaze (ALT) 
i glutamat dehidrogenaze (GLDH) u zamorčića (Cavia porcellus). Osim toga, istražen je utjecaj premedikacije 
kloramfenikolom na trajanje anestezije pentobarbitalom i kombinacijom ksilazin/ketamin. Zamorčićima 
muškoga spola, težine 269-353 g, supkutano je apliciran kloramfenikol u obliku natrijeva sukcinata u dozi 60 i 
100 mg/kg tjelesne mase tijekom tri uzastopna dana. Nakon toga primijenjeni su anestetici: prvoj skupini 30 mg 
pentobarbitala/kg t.m., i.p. i drugoj skupini 60 mg ketamina i 4 mg ksilazina/kg t.m., s.c. Rezultati su pokazali 
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da kloramfenikol nije značajno utjecao na koncentaraciju ALT i GLDH u serumu. Međutim, kloramfenikol 
u dozi od 100 mg/kg t.m. značajno je umanjio aktivnost Ah i EtND, i to za -36,1% i -38,6%. S druge strane, 
trajanje anestezije nakon primjene pentobarbitala i kombinacije ketamina i ksilazina u zamorčića prethodno 
obrađenih kloramfenikolom nije bilo statistički značajno produženo. Naši rezultati upućuju na to da umanjena 
aktivnost biotransformacijskih enzima nakon primjene kloramfenikola nije utjecala na jetreni metabolizam 
dvaju testiranih anestetika u zamorčića te da primjena kloramfenikola nije produžila vrijeme trajanja anestezije 
što je suprotno nalazima kod pasa, mačaka, štakora i miševa.
Ključne riječi: kloramfenikol, pentobarbital, ketamin/ksilazin, biotransformacija, alanin aminotransferaza, 
glutamat dehidrogenaza, zamorčić (Cavia porcellus)
